Silent Fc variants of anti-CD40 antibodies
US8828396B2 · kind B2 · utility
22Cited by
17References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 14, 2011 |
| Grant date | Sep 9, 2014 |
| Priority date | — |
| Expiry date | Nov 14, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/71
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to silent Fc variants of anti-CD40 antibodies and compositions and methods of use of said antibodies for treating pathological disorders such as autoimmune and inflammatory disorders and/or for preventing or reducing the risk of graft rejection in transplantation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.